Skip to main content

Table 2 Clinical and resistant characteristics of clinical linezolid-resistant Staphylococcus capitis

From: Clonal dissemination of linezolid-resistant Staphylococcus capitis with G2603T mutation in domain V of the 23S rRNA and the cfr gene at a tertiary care hospital in China

Strain designation Ward Resource Isolation(yy/mm/dd) Linezolid usage (total dose/days) MIC ( μg/mL) cfr Mutations in domain V of the 23S rRNA gene
LZD VAN Q/D CLI
SA10106 ICU catheter 2012/9/10 7.8 g/13 days >256 1 >=8 2 + G2603T
SA13096 IDD blood 2012/9/13 >256 <=0.5 >=8 2 + G2603T
SA23062 ICU blood 2013/6/23 8.4 g/14 days >256 1 >=8 2 + G2603T
SA20062 ICU blood 2013/7/20 13.2 g/22 days >256 <=0.5 >=8 2 + G2603T
SA11026 ICU blood 2014/2/11 >256 <=0.5 >=8 2 + G2603T
  1. Note: ICU: intensive care unit; IDD: the department of infectious diseases; LZD: linezolid; VAN: vancomycin; Q/D: quinupristin/dalfopristin; CLI: clindamycin; −, no linezolid treatment.